Dext Capital closed on Dext ABS 2023-1, the company’s third securitization and its largest to date. The $293 million transaction secured orders from 15 new investors and 22 in total. The proceeds will be used to finance equipment leases across a range of asset classes in the healthcare space, including surgical, diagnostic and pharmaceutical equipment.

“We’re thrilled with the level of engagement from investors, which I view as a testament to the quality of our prior transactions, the performance of our portfolio and our team’s expertise,” Conrad Nilsen, senior vice president of finance at Dext Capital, said. “The ABS market continues to play an important role in Dext’s funding strategy.”

Dext ABS 2023-1 was co-led by Bank of America and Truist Bank, with Regions Bank acting as co-manager. Mayer Brown served as issuer’s counsel.